Login / Signup

Single-use IgE-selective immunoadsorber column for the treatment of severe atopic dermatitis.

Damian MeyersburgMartin LaimerAndrea KuglerEva MühlthalerNadja LindlbauerWolfgang HitzlEva RohdeJohann W BauerChristoph Grabmer
Published in: Journal of clinical apheresis (2019)
Data of this preliminary trial indicates clinical efficacy, feasibility, safety as well as tolerability of IgE-selective IA in AD.
Keyphrases
  • atopic dermatitis
  • clinical trial
  • study protocol
  • electronic health record
  • phase iii
  • big data
  • randomized controlled trial
  • phase ii
  • liquid chromatography
  • combination therapy
  • mass spectrometry
  • placebo controlled